Edoxaban for the Treatment of Coagulopathy in Patients With Active Cancer and Acute Ischemic Stroke: a Pilot Study. (ENCHASE Study)
Clinical trial NCT03570281 · UNKNOWN
Trial details
- NCT number
- NCT03570281
- Sponsor
- Samsung Medical Center
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-15
- Primary completion
- 2020-05-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.